The scandal of generic drug pricing: drug regulation policies need review

BMJ. 2017 Feb 23:356:j947. doi: 10.1136/bmj.j947.

Authors

Karim Meeran¹, Sirazum M Choudhury², John Wass³

Affiliations

¹ Department of Endocrinology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London W6 8RF, UK.
² Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, Charing Cross Hospital.
³ Churchill Hospital, Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK.

PMID: 28232321
DOI: 10.1136/bmj.j947

No abstract available

Publication types

Letter

MeSH terms

Cost Control
Costs and Cost Analysis
Drug Costs
Drug Industry / economics*
Drugs, Generic / economics*
Economics, Pharmaceutical
Humans
Policy Making
United Kingdom

Substances

Drugs, Generic